Violet Defense
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $20M
Investors
- 2
About Violet Defense
00 mn from Katalyst Securities and Kirenaga Partners. The company was established by Mark Nathan, who has a history of founding other ventures.Violet Defense, LLC provides a range of UV light disinfection products tailored to address specific challenges in healthcare, education, and commercial sectors. These products were released strategically to meet the growing need for effective disinfection solutions in environments prone to infectious pathogens.The revenue model of Violet Defense, LLC is structured around B2B sales, facilitating direct transactions with various clients. Engagement typically occurs through partnerships and direct sales, ensuring a continual exchange of value. Their flagship products in the UV disinfection space are competitively priced to reflect their effectiveness and align with customer needs. The company intends to enhance its existing offerings while exploring opportunities in Asian markets by the end of 2023, ensuring a wider adoption of its disinfection solutions.
Who invested in Violet Defense
2 investors across 2 rounds
See all investors in Violet Defense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Violet Defense
Who invested in Violet Defense?
Violet Defense has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Violet Defense raised?
Violet Defense has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Violet Defense last raise money?
Violet Defense's most recent round on record is a Series B, in Nov 2021.
What does Violet Defense do?
00 mn from Katalyst Securities and Kirenaga Partners.
Where is Violet Defense headquartered?
Violet Defense is headquartered in Orlando, US.
Which VCs invest in companies like Violet Defense?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Violet Defense's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Violet Defense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.